Announcements Trials
Browse Landscape

Phase

Phase 2 67Phase 3 16Phase 1/2 10Phase 4 9Phase 1 6Phase NA 2Phase 2/3 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 437Breast 401Genitourinary 270Thoracic 187Gynecologic 140Head & Neck 129Other hematologic neoplasm 127Lymphoid 115CNS 103Dermatologic 89Tumor-Agnostic 85Plasma cell 59Sarcoma 56Myeloid 49Other 40Endocrine 26Classical hematology 21Other solid neoplasm 14Other neoplasm 14NET 2

Conditions

Neuroendocrine Tumors 2Prostatic Neoplasms 1

Interventions

177Lu-DOTA-JR11 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Has results × NET × Clear all
NCT05680675 2025-02-06

Dual-Tracer Theranostic PET

University of Utah

Phase NA Completed
50 enrolled 8 charts
EndocrineGenitourinaryNET

Prostatic Neoplasms, Neuroendocrine Tumors

NCT02609737 2022-02-01

Theranostics of Radiolabeled Somatostatin Antagonists 68Ga-DOTA-JR11 and 177Lu-DOTA-JR11 in Patients With Neuroendocrine Tumors

Memorial Sloan Kettering Cancer Center

Phase NA Completed
20 enrolled 8 charts
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡